6th September 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Cipla, JB Chemicals, and Torrent leading Rs 4,500-crore race for Medley Pharma

Cipla, KKR-owned JB Chemicals, and Torrent Pharmaceuticals NSE 0.06% are competing for the right to buy Medley Pharmaceuticals in a deal estimated to be worth $4,500 crore.

CDSCO Panel Orders Sun Pharma to Conduct Phase III for Psoriasis Drug Tildrakizumab

Subject Expert Committee under the control of CDSCO has recommended Sun Pharma, a major pharmaceutical company, to conduct a Phase III bridging clinical trial with at least 100 patients, 5% of whom should have psoriasis with tuberculosis.

India seeks drug market access in South America

In the $58 billion South American market, India is pushing for preferential market access for pharmaceutical products like generics, active pharmaceutical ingredients (APIs), and alternative medicines.

India MD: GSK's pharmaceutical brands doing well

GlaxoSmithKline Pharmaceuticals said its top medicine brands, including Augmentin, Calpol, and Supacef, are maintaining market share, and that the recent price increase and partial stabilisation of raw material prices will help it maintain operating margins in FY23.

As per AWACS, Indian pharmaceutical market grew 12.1% in August

According to market research company AWACS, the Indian pharmaceutical market (IPM) expanded strongly across all therapy areas in August, growing 12.1% in value and 4.8% in volume.

Azurity Pharma's Konvomep approved by USFDA to treat active benign gastric ulcers

USFDA has approved Konvomep, according to Azurity Pharmaceuticals, Inc., a pharmaceutical company dedicated to creating novel dose-forms and product formulations to meet the needs of underserved patients.

USFDA approves SPEVIGO to combat flare-ups of generalised pustular psoriasis

SPEVIGO, the first approved treatment option for generalised pustular psoriasis (GPP) flares in adults, has been approved by the U.S. Food and Drug Administration (USFDA), according to a statement from Boehringer Ingelheim.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?